Stockreport

BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer [Yahoo! Finance]

BeiGene, Ltd. - American Depositary Shares  (BGNE) 
Last beigene, ltd. - american depositary shares earnings: 3/2 04:05 pm Check Earnings Report
PDF Decision represents tislelizumab's second approval in the region BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass., April 23, 2024 BUSINESS WIRE )--BeiGene, Ltd. (NASDA [Read more]